• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
      • shARC Platform
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us
  • Home
  • Newsroom
  • Media Center

Media Center

Celyad Oncology Corporate Fact Sheet

Corporate Overview Fact Sheet

Allogeneic Vs. Autologous Fact Sheet

Allogeneic vs. Autologous Fact Sheet

KEYNOTE-B79 Trial Fact Sheet

KEYNOTE-B79 Trial Fact Sheet

IMMUNICY Trial Fact Sheet

IMMUNICY Trial Fact Sheet

What is NKG2D?

NKG2D Fact Sheet

shRNA Fact Sheet

shRNA Fact Sheet

What is TIM Technology?

TIM Fact Sheet

CAR T vs NK Cells

CAR T vs NK Cells

Celyad Oncology Logo

Celyad Oncology Headquarters

Lab Image

Lab Image

Celyad Oncology Manufacturing Building

Philippe Dechamps

Frédéric Lehmann

Philippe Nobels

Charles Morris

Load More

Footer

Celyad Oncology

Celyad Oncology
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use